Acuitas Medical Limited, a Swansea, UK-based MRI software company (formerly known as OsteoTronix), has secured a £700,000 co-investment from Finance Wales and Altima Global Special Opportunities Master Fund (Altima).
Commenting on the funding, John P. Heinrich, Ph.D., chairman and CEO of Acuitas Medical, was quoted as saying: “The investment by Finance Wales and additional investment from Altima will enable us to further develop the fTA™ software and evaluate clinical applications including angiogenesis (the network of blood vessels that supports tumour growth), organ fibrosis, breast cancer, bone diseases, and other pathologies characterised by fine structural changes.
“Ultimately we expect to improve MR utilisation and work flow by rapidly providing superior diagnostic information”, he added.
FinSMEs
09/08/2010